Introduction
============

An increasing number of posterior segment disorders are successfully managed with pars plana vitrectomy (PPV). These disorders include retinal detachments, macular holes, epiretinal membranes, vitreous hemorrhages or opacities, and macu-lar hemorrhages. Cataract development is a frequent postoperative complication, with an incidence rate varying from 12.5% to 80%.[@b1-opth-12-989]--[@b8-opth-12-989] Although the exact cause of cataract formation is unclear, it has been associated with patient age,[@b9-opth-12-989],[@b10-opth-12-989] preexisting nuclear sclerosis,[@b9-opth-12-989] length of surgery,[@b11-opth-12-989] lens injury during PPV,[@b12-opth-12-989] prolonged exposure to an intravitreal light source,[@b13-opth-12-989] diabetic retinopathy,[@b14-opth-12-989],[@b15-opth-12-989] the type of infusion fluid or cannula,[@b16-opth-12-989] and the use of intraocular gas or silicone oil.[@b4-opth-12-989],[@b10-opth-12-989] Small-gauge PPV systems are potentially less risky than previous 20-gauge PPV systems due to reduced balanced salt solution consumption, lower intravitreal fluid flow, decreased surgical time, and ocular manipulation.[@b17-opth-12-989] Phacoemulsification is associated with smaller incision size, less induced astigmatism, faster visual rehabilitation, and fewer complications. With progressive improvements in vitreoretinal or cataract surgical techniques and new devices, more scientific research is now needed to monitor updated surgical outcomes after phacoemulsification in vitrectomized eyes. We report a large series of 87 vitrectomized eyes in which phacoemulsification with intraocular lens (IOL) implantation was performed. The primary endpoint was to describe the outcomes after cataract surgery (CS) in vitrectomized eyes. The secondary endpoint was to analyze whether the time of cataract development is related to patients' characteristics at PPV (general or ophthalmologic).

Patients and methods
====================

Eighty-seven consecutive patients (87 eyes) with previous PPV who underwent phacoemulsification and IOL implantation between June 2013 and December 2016 were retrospectively reviewed. The protocol for this study was approved by our institution's ethics committee (Institut Catala de Retina). Written informed consent was obtained from all patients before the surgery was performed, and this consent also included the use of their medical data for research. The study and data accumulation were performed in conformity with Spanish and European laws and in adherence to the tenets of the Declaration of Helsinki.

The data regarding the patient demographics, indication for PPV with Constellation (Alcon Laboratories, Fort Worth, TX, USA) or Stellaris (Bausch & Lomb, Bridgewater, NJ, USA) vitrectomy system, degree of myopia, visual acuity (VA) before and at 3 months after PPV, prior crystalline lens status, type of vitreous substitute used, and the duration between PPV and phacoemulsification surgery were obtained. The preoperative evaluation before CS included age at surgery, VA, slit-lamp examination, morphology or type of cataract, and optical biometry (IOL master Carl Zeiss Meditec V.5, Carl Zeiss Meditec, Jena, Germany). Axial length was measured using immersion scan in 2 cases in which optical biometry resulted in error. Type and power of IOL used and intraoperative complications were noted. A toric monofocal IOL was placed only in cases with astigmatism greater than 1.50 D, and a trifocal IOL was placed only in eyes without previous macular pathology, normal corneal topography, normal macular optical coherence tomography (OCT), and normal visual field. CS was planned to be performed as routine phacoemulsification under topical or peribulbar anesthesia (Infinity^®^ or Centurion^®^ Vision System, Alcon Laboratories). All PPVs in this study were done by 4 experienced surgeons (AR, IJ, XM, and PP), and CS was done by a single surgeon (AR).

Postoperative complications and date of last follow-up after phacoemulsification were noted. VA at the last visit was recorded and compared with preoperative VA. OCT was also performed in all patients to exclude macular edema within 2 months after CS.

Crystalline lens status was determined clinically with the slit-lamp and graded as clear, trace, mild (1+), moderate (2+), severe nuclear sclerosis (3+), or very severe cataract when fundus was not visible (4+).[@b9-opth-12-989] Type of cataract included posterior subcapsular, nuclear sclerotic, and anterior cortical cataracts.[@b1-opth-12-989]

The results were statistically analyzed using the SPSS software version 16.0 (SPSS, Inc., Chicago, IL, USA) and presented as frequency, percentage (%), and mean ± SD. Parametric data were compared using one-way analysis of variance and nonparametric data using Mann--Whitney test. Correlations were evaluated using the Pearson correlation coefficients and multivariate cox regression analysis. The Kaplan--Meier method and log-rank (Mantel--Cox) test were applied. A *p*-value of \<0.05 was considered statistically significant with a confidence interval of 95%.

Results
=======

Eighty-seven eyes of 87 patients were included in the study. Demographic and ocular characteristics at PPV are shown in [Table 1](#t1-opth-12-989){ref-type="table"}. Demographic and ocular characteristics at CS are shown in [Table 2](#t2-opth-12-989){ref-type="table"}.

Topical anesthesia was used in 63 eyes (72.4%), and a monofocal IOL was placed in 65 eyes (74.7%), a toric monofocal IOL in 21 (24.2%), and a trifocal IOL in only 1 (1.1%). Mean power of the IOL was +18 D (range: 1--28.5). The IOLs were placed successfully in the capsular bag in all cases. Intraoperative complications included anterior rhexis tear (1 eye) and hyphema (1 eye). Inadequate fundus reflex was evidenced in 2 eyes, and miosis occurred in 6 eyes (1 eye required iris retractors and 5 eyes intracameral phenylephrine). Postoperative complications included cys-toid macular edema (CME: 15 eyes) at a mean of 42 days (range: 19--120), posterior capsule opacification (PCO) which required Nd:YAG laser (12 eyes) at a mean of 14 months (range: 4--35), ocular hypertension (10 eyes), and anterior uveitis (1 eye). Ten out of the 15 eyes with postoperative CME had previous epiretinal membrane, none of these patients were diabetic, and the edema resolved after topical treatment (4 eyes), subtenon steroids (9 eyes), intravitreal steroids (1 eye), and PPV with membrane peeling (1 eye) ([Table 3](#t3-opth-12-989){ref-type="table"}). Mean follow-up duration after CS was 14.5 months (range: 6--50).

Preoperative mean corrected distance VA improved from 20/50 to 20/25, with a mean increase of 4.48 Snellen lines (*p*\<0.001). Preoperative mean near corrected VA improved from 20/32 to 20/25; *p*\<0.001. Preoperative mean spherical equivalent refraction improved from −4.35±4.21 D (range: −20 to +2.75) to −0.17±0.57 D (range: −3.25 to +0.75) after CS (*p*\<0.001) ([Figure 1](#f1-opth-12-989){ref-type="fig"}). Final VA of 20/40 or better was achieved in 95% of the eyes after phacoemulsification ([Table 4](#t4-opth-12-989){ref-type="table"}). In total, 25% of the patients had residual symptoms: 17 had metamorphopsia (6/17 severe), 4 diplopia (2 required prism correction), and 1 a central scotoma after CS.

Patients \>55 years (n=61) when undergoing PPV had earlier CS than younger patients (10.6 vs 37.7 months; *p*=0.025). Eyes with clear lens prior to the PPV (n=45) had later CS than eyes with some degree of cataract (27.1 vs 9.7 months; *p*=0.016), ([Figure 2](#f2-opth-12-989){ref-type="fig"}). Eyes with gas tamponade (n=69) were operated earlier than eyes without a tamponade, but the difference was not statistically significant (16.7 vs 26.2 months; *p*=0.393). In addition, myopia (16.9 months in myopic eyes vs 20.8 months in nonmyopic eyes; *p*=0.602) and axial length did not correlate with the time of the CS (Pearson correlation coefficient: +0.189; *p*=0.116). Multivariate Cox regression analysis results for CS are summa-rized in [Table 5](#t5-opth-12-989){ref-type="table"}. Age and lens status at PPV was found to be associated with CS.

If the groups are separated by lens state prior to PPV, patients \>55 years with clear lens at PPV (n=21) had earlier CS than younger ones with clear lens (n=24) (11.8 vs 40.5 months; *p*=0.033). The Kaplan--Meier method and log-rank (Mantel--Cox) test were applied to the data for patients with clear lens classified into 2 groups according to age ≤ or \>55 years (*p*=0.005) ([Figure 3](#f3-opth-12-989){ref-type="fig"}).

Eyes with clear lens at PPV operated with gas (n=36) had earlier CS than eyes with clear lens at PPV in which gas was not used (n=9), but this result was not statistically significant (23.6 vs 41.3 months; *p*=0.416). Axial length or the presence of myopia in eyes with clear lens prior to PPV did not correlate with the time of the CS after PPV (24.4 vs 29.7 months; *p*=0.328).

Discussion
==========

As vitreoretinal surgical techniques and outcomes improve and indications for PPV expand, the rate of cataract extraction after PPV is increasing. In our study, we evaluated intraoperative and postoperative complications and visual outcomes after phacoemulsification in previously vitrectomized eyes. We also analyzed the mean time from CS to PPV taking into account age and lens status prior to PPV, myopia and axial length, and the use of a gas tamponade.

In our series, the mean interval from PPV to CS was 18 months, with 19% of the cataracts operated on within 6 months, 63% within 1 year, and 72% within 2 years. Our study demonstrates that the majority of postvitrectomy cataracts developed relatively quickly in the postoperative period. The high incidence of nuclear sclerosis is consistent with the findings of other studies.[@b1-opth-12-989],[@b2-opth-12-989],[@b6-opth-12-989],[@b18-opth-12-989],[@b19-opth-12-989]

An unusually deep anterior chamber during phacoemulsification was first described by Yeoh[@b20-opth-12-989] in vitrectomized eyes. This makes CS especially challenging in these cases. Some aspects that may help to prevent fluctuation of the anterior chamber are keeping the infusion bottle low, constructing an accurately sized and clear corneal incision to maintain a relatively sealed chamber during surgery, or adding adrenaline to the infusion solution to keep the pupil dilated. However, with the modern phacoemulsification machines we used, intraoperative miosis was only observed in 7% of the eyes in our study, in which intracameral mydriatics or iris hooks were successfully used. Capsulorhexis may also be difficult in these eyes because of a very deep anterior chamber and the lack of the counterpressure exercised by the vitreous, especially in myopic eyes (45% of our cases). However, we only had 1 small anterior rhexis tear and 1 eye with transient hyphema because of iris trauma. In eyes with very early cataract development within 4 months after PPV (6 eyes in our study), lens touch with posterior capsule rupture has to be considered.[@b12-opth-12-989],[@b21-opth-12-989] Thus, a thorough hydrodissection, adequate lens rotation, and gentle nucleus manipulation must be performed to avoid unnecessary zonular stress or posterior capsule tears. Fortunately, we did not have any zonular dehiscence or posterior capsule rupture. In a recent study,[@b12-opth-12-989] the incidence of lens touch after PPV was 3.7%, and during the subsequent CS in this group, 11% had a posterior capsule rupture.

In the current study, the most frequent postoperative complications were CME and PCO. Postoperative CME was found after a mean time of 42 days, mostly in patients with prior epiretinal membrane. Thus, we recommend performing a macular OCT routinely to detect this complication at an early stage, within 2 months, or in all patients whose vision decreases after surgery. In a recent study, neither CME was noted at 12 weeks follow-up[@b4-opth-12-989] nor was this observed in a previous case series after 6 weeks follow-up;[@b5-opth-12-989] however, OCT was not routinely used. PCO was found after a mean of 14 months and Nd:YAG capsulotomy was performed. Some studies found that the incidence of PCO was higher in vitrectomized eyes compared with nonvitrectomized eyes.[@b2-opth-12-989],[@b22-opth-12-989]

In our study, significant improvement in uncorrected and corrected distance or near vision was observed postoperatively after phacoemulsification. Although it has been reported that biometry is not always accurate in eyes that have had PPV,[@b4-opth-12-989] we achieved a final spherical equivalent of −0.17 after CS. VA improved by more than 2 Snellen lines in 91% of our cases, and 95% of the eyes achieved VA ≥20/40 after CS. However, visual function depended on the underlying retinal disease, and 25% of our patients had residual symptoms including metamorphopsia, diplopia, or central scotoma after CS.

The development of postvitrectomy cataract appears to be multifactorial. In our study, patients of advanced age with clear lens at PPV had significantly earlier CS than the younger ones with clear lens (12 vs 41 months). Thus, age at PPV may be a risk factor for cataract development after PPV. Thompson reported that vitrectomized eyes of young patients had small increases in nuclear sclerosis (0.12 grades/yr) and that eyes of patients of advanced age had substantial progression (0.81 grades/yr).[@b10-opth-12-989]

Eyes with some degree of cataract prior to PPV also significantly influenced the need for cataract removal, and such eyes had earlier CS than eyes with prior clear lens (10 vs 27 months). These results are consistent with other studies in which progression of postvitrectomy nuclear sclerosis generally occurred in eyes with a higher degree of preoperative lens opacity.[@b9-opth-12-989] Thus, lens status at PPV may be a risk factor for cataract development after PPV.

Eyes with gas tamponade were operated on earlier than eyes without tamponade, but this was not statistically significant. Two previous studies found no effect of intraocular gas bubbles on cataract progression.[@b13-opth-12-989],[@b18-opth-12-989] However, Thompson[@b10-opth-12-989] found that PPV with gas--fluid exchange was more cataractogenic, with a nuclear sclerosis increase of 60% compared with eyes without gas.

In addition, in our series, myopia and axial length did not correlate with the time of the CS after PPV. These findings have not been previously reported. Other intraoperative variables, such as the type of infusion fluid, position of the infusion cannula, and the type of light source, remained constant in our study and could not be analyzed.

Limitations of the current study are the retrospective design, the relatively small number of subjects, and the variable follow-up duration. Another limitation is that cataracts were graded subjectively by the surgeon with the slit-lamp rather than by a masked examiner evaluating standard lens photographs.

Conclusion
==========

In conclusion, our study demonstrates that patient age and the presence of preoperative nuclear sclerosis are important risk factors in determining the time of cataract development, whereas axial length or the presence of myopia had no effect in vitrectomized eyes. Although eyes with intraocular gas were operated on earlier, this difference was not statistically significant. Thus, the effect of gas is still controversial. Progression of nuclear cataracts leads to substantial visual loss during the first year after vitrectomy in most patients, and surgeons should know the special characteristics of the vitrectomized eyes to prevent complications. Despite being challenging cases, good visual rehabilitation can be expected, limited by the underlying retinal disease, which should be taken into consideration when advising patients.
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![(**A**) Mean UDVA and CDVA prior to and after CS (*p*\<0.001). (**B**) Mean CNVA prior to and after CS (*p*\<0.001). (**C**) Mean SE prior to and after CS (*p*\<0.001).\
**Abbreviations:** CDVA, corrected distance visual acuity; CNVA, corrected near visual acuity; CS, cataract surgery; J, Jaeger; SE, spherical equivalent; UDVA, uncorrected distance visual acuity.](opth-12-989Fig1){#f1-opth-12-989}

![Eyes with clear lens prior to the PPV (n=45) had significantly later CS than eyes with some degree of cataract (27.1 vs 9.7 months; *p*=0.016).\
**Abbreviations:** CS, cataract surgery; PPV, pars plana vitrectomy.](opth-12-989Fig2){#f2-opth-12-989}

![(**A**) Patients aged \>55 years with clear lens at PPV (n=21) had significantly earlier CS than younger ones with clear lens (n=24); (11.8 vs 40.5 months; *p*=0.033). (**B**) The Kaplan--Meier method and log-rank (Mantel--Cox) test were applied to data for patients with clear lens classified into 2 groups according to age ≤ or \>55 years (*p*=0.005).\
**Abbreviations:** CS, cataract surgery; PPV, pars plana vitrectomy.](opth-12-989Fig3){#f3-opth-12-989}

###### 

Demographic and ocular characteristics at PPV

  Demographic and ocular characteristics at PPV   
  ----------------------------------------------- -----------------------------------------------------------------------------------------------------------------------------------------------------
  Gender                                          46 women, 41 men
  Age                                             60±8 years (25--75)
  Lens state                                      51.7% clear lens, 29.9% trace nuclear sclerosis, 14.9% mild cataract (1+), 3.4% moderate cataract (2+)
  Myopia                                          44.8% (mean −5.20 D)
  Primary indications for PPV                     64.4% retinal detachment, 14.9% macular hole, 12.6% epiretinal membrane, 5.7% vitreous hemorrhage, 1.1% vitreous opacities, 1.1% macular hemorrhage
  Gas at PPV                                      79.3%
  VA prior to PPV                                 20/63 (hand movement to 20/20)
  VA at 3 months after PPV                        20/32 (hand movement to 20/20)

**Abbreviations:** PPV, pars plana vitrectomy; VA, visual acuity.

###### 

Demographic and ocular characteristics at CS

  Demographic and ocular characteristics at CS   
  ---------------------------------------------- ------------------------------------------------------------------------------------------
  Gender                                         46 women, 41 men
  Age                                            61.5±8 years (41--75)
  Mean interval from PPV to CS                   18.8 months (1--207)
  Lens state                                     75.9% moderate cataract (2+), 21.8% severe cataract (3+), 2.3% very severe cataract (4+)
  Cataract type                                  86.2% nuclear, 11.5% posterior subcapsular, 2.3% anterior cortical cataract
  Mean axial length                              25.14±2.16 mm (21.79--34.28)
  Mean astigmatism                               −1.17±0.89 D (0 to −4.65)
  Mean anterior chamber depth                    3.16±0.38 mm (2.28--4.38)
  VA prior to CS                                 20/50 (counting fingers to 20/25)
  Final VA after CS                              20/25 (20/125 to 20/20)

**Abbreviations:** CS, cataract surgery; PPV, pars plana vitrectomy; VA, visual acuity.

###### 

Intraoperative and postoperative complications of CS

  Complications of CS                                                                                                         N=87 eyes
  --------------------------------------------------------------------------------------------------------------------------- ------------
  Intraoperative                                                                                                              
   Miosis                                                                                                                     6 (6.9%)
   Inadequate fundus reflex                                                                                                   2 (2.3%)
   Hyphema                                                                                                                    1 (1.1%)
   Anterior rhexis tear                                                                                                       1 (1.1%)
   Posterior capsule rupture, zonular dehiscence, or vitreous loss                                                            0 (0%)
  Postoperative                                                                                                               
   CME                                                                                                                        15 (17.2%)
   PCO                                                                                                                        12 (13.8%)
   Ocular hypertension                                                                                                        10 (11.5%)
   Anterior uveitis                                                                                                           1 (1.1%)
   Retinal detachment, endophthalmitis, corneal wound leakage, reopened macular hole, dislocated IOL or vitreous hemorrhage   0 (0%)

**Abbreviations:** CME, cystoids macular edema; CS, cataract surgery; IOL, intra-ocular lens; PCO, posterior capsule opacification.

###### 

CDVA prior to and after PPV CS

  CDVA                     CDVA prior to PPV   CDVA after PPV   CDVA prior to CS   CDVA after CS                         
  ------------------------ ------------------- ---------------- ------------------ --------------- ------ ------- ------ -------
  CDVA ≤20/200             n=31                35.6%            n=3                3.4%            n=11   12.6%   n=0    0%
  CDVA 20/200--20/40       n=29                33.3%            n=19               21.8%           n=36   41.4%   n=4    4.6%
  CDVA ≥20/40              n=30                34.5%            n=68               78.2%           n=43   49.4%   n=83   95.4%
  CDVA ≥2, Snellen lines   N/A                 N/A              n=64               73.5%           N/A    N/A     n=79   90.8%

**Abbreviations:** CDVA, corrected distance visual acuity; CS, cataract surgery; N/A, not applicable; PPV, pars plana vitrectomy.

###### 

Multivariate cox regression analysis for CS

  Variables     *df*   Parameter estimate   Standard error   *χ*^2^   *p*-values   Hazard ratio
  ------------- ------ -------------------- ---------------- -------- ------------ --------------
  Age           1      0.648                0.087            4.804    0.028        1.912
  Gas           1      −0.016               0.081            3.118    0.077        0.983
  Myopia        1      −0.241               0.078            7.320    0.567        0.786
  Lens status   1      0.902                0.085            11.170   0.001        2.465

**Abbreviation:** CS, cataract surgery.
